Granules India Ltd.

Aug 09, 2022 17:57 Source: BSE

Granules India - Record Date Of Buy-Back

Record date of Buy-Back

Aug 09, 2022 17:26 Source: BSE

Granules India - Announcement under Regulation 30 (LODR)-Investor Presentation

Presentation to the Analysts/Investors for the earnings calls scheduled on August 10, 2022.

Aug 09, 2022 17:17 Source: BSE

Granules India - Financial Result For The Quarter Ended June 30,2022.

Financial Result for the Quarter ended June 30,2022.

Aug 01, 2022 12:19 Source: NSE

Granules India Limited

Granules India Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call

Aug 01, 2022 11:33 Source: NSE

Granules India Limited

Granules India Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call

Aug 01, 2022 11:01 Source: BSE

Granules India - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Schedule of Earnings Conference call for Q1 of FY2022-23

Jul 29, 2022 10:28 Source: BSE

Granules India - Board Meeting Intimation for Inter-Alia, To Consider And Approve The Un-Audited Financial Results For The First Quarter Ended On June 30, 2022 And To Consider A Proposal For Buyback Of Equity Shares Of The Company.

GRANULES INDIA LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2022 ,inter alia, to consider and approve the un-audited financial results for the first quarter ended on June 30, 2022 and to consider a proposal for buyback of equity shares of the Company.

Jul 23, 2022 8:29 Source: BSE

Granules India - The US FDA Completed An Inspection Of The Facility Of Granules Pharmaceuticals, Inc.

The US FDA completed an inspection of the facility of Granules Pharmaceuticals, Inc.

Jul 13, 2022 12:56 Source: BSE

Granules India - Statement Of Investor Complaints For The Quarter Ended June 2022